The global Reishi mushroom market size reached USD 4.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6.6% during 2025-2033. The rising prevalence of chronic and acute indications, augmenting demand for natural and organic products, and rapid product utilization in dietary supplements represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 4.2 Billion |
Market Forecast in 2033
|
USD 7.4 Billion |
Market Growth Rate 2025-2033 | 6.6% |
Reishi mushroom, also known as Ganoderma lucidum, is a type of medicinal mushroom that has been used in traditional Chinese medicine for thousands of years due to its purported health benefits. A large, dark-colored edible mushroom with a thick reddish-brown cap, distinctive glossy surface, and a woody texture, it is consumed in dried or powdered form, or as an extract in supplements. Reishi mushroom is known for its anti-inflammatory, antioxidant, anti-tumor and immune-boosting properties. It contains a variety of active compounds, including triterpenoids, polysaccharides, and peptidoglycans, which contribute to its medicinal properties. Reishi mushrooms provide several medical benefits, such as stimulating the production of white blood cells and other immune cells, helping improve cognitive function, reducing stress, boosting energy levels, while being rich in anti-inflammatory properties that can help to reduce inflammation throughout the body.
The market is majorly driven by the rising demand for natural and organic products across the globe. This can be attributed to the growing awareness regarding numerous medicinal properties of the mushroom among the consumers. In line with this, the paradigm shift toward natural remedies for chronic diseases, such as diabetes, obesity and cardiovascular diseases, is providing an impetus to the market. Also, the increasing prevalence of chronic diseases, along with the growing geriatric population that is more susceptible to developing these ailments, is creating a positive market outlook. In addition to this, the rapid product utilization in the formulation of a wide range of dietary supplements is propelling the demand for Reishi mushroom. The market is further fueled by the rising popularity of Reishi mushrooms as an alternative to animal-based products in vegan diets due to their high nutritional value. Apart from this, favorable government policies in several countries supporting the cultivation of Reishi mushroom is also acting as a significant growth-inducing factor for the market. Furthermore, the augmenting demand for natural and organic beauty products where Reishi mushroom is used as an anti-aging and anti-inflammatory agent is impacting the market positively. Some of the other factors contributing to the market include the emerging trend of veganism, inflating disposable income levels, and extensive research and development (R&D) activities.
IMARC Group provides an analysis of the key trends in each segment of the global Reishi mushroom market, along with forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on form, nature, and end user.
Form Insights:
The report has provided a detailed breakup and analysis of the Reishi mushroom market based on the form. This includes liquid and powder. According to the report, powder represented the largest segment.
Nature Insights:
The report has provided a detailed breakup and analysis of the Reishi mushroom market based on the nature. This includes organic and conventional. According to the report, conventional represented the largest segment.
End User Insights:
A detailed breakup and analysis of the Reishi mushroom market based on the end user has also been provided in the report. This includes food and beverages, pharmaceutical, nutraceutical and dietary supplement, and cosmetics and personal care. According to the report, pharmaceutical, nutraceutical and dietary supplement accounted for the largest market share.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific was the largest market for Reishi mushroom. Some of the factors driving the Asia Pacific Reishi mushroom market included the growing geriatric population susceptible to chronic ailments, escalating demand for natural and organic products, inflating disposable income, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global reishi mushroom market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alphay International Inc., Bio-Botanica, Bristol Botanicals Limited, DXN Holdings Bhd, Hokkaido Reishi, Mushroom Science, Nammex, Qingdao Dacon Trading Co., Ron Teeguarden Enterprises Inc, The Mushroom Company, Xi'an Greena Biotech Co. Ltd, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Forms Covered | Liquid, Powder |
Nature Covered | Organic, Conventional |
End Users Covered | Food and Beverages, Pharmaceutical, Nutraceutical and Dietary Supplement, Cosmetics and Personal Care |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Alphay International Inc., Bio-Botanica, Bristol Botanicals Limited, DXN Holdings Bhd, Hokkaido Reishi, Mushroom Science, Nammex, Qingdao Dacon Trading Co., Ron Teeguarden Enterprises Inc, The Mushroom Company, Xi'an Greena Biotech Co. Ltd, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |